HemaSphere
(Jul 2022)
Impact of Comorbidities on Health-related Quality of Life in Nontransplant Eligible Patients With Newly Diagnosed Multiple Myeloma
- M. Christine Bennink,
- Claudia A. M. Stege,
- Birgit I. Lissenberg-Witte,
- Simone Oerlemans,
- Maarten R. Seefat,
- Pieter Sonneveld,
- Sonja Zweegman
Affiliations
- M. Christine Bennink
- 1 Department of Haematology, Erasmus University Medical Center, Rotterdam, the Netherlands
- Claudia A. M. Stege
- 3 Department of Haematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands
- Birgit I. Lissenberg-Witte
- 4 Department of Epidemiology and Data Science, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, the Netherlands
- Simone Oerlemans
- 5 Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands
- Maarten R. Seefat
- 3 Department of Haematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands
- Pieter Sonneveld
- 6 Department of Haematology, Erasmus University Medical Center, Rotterdam, the Netherlands
- Sonja Zweegman
- 3 Department of Haematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands
- DOI
-
https://doi.org/10.1097/HS9.0000000000000744
- Journal volume & issue
-
Vol. 6,
no. 7
p.
e744
WeChat QR code